Our Research.

We discover personalized medical solutions for environmentally triggered diseases.

Our Research.

We discover personalized medical solutions for environmentally triggered diseases.

How Foundation Models Are Shaping Biomedical Research

AI-powered foundation models like GPT have evolved from everyday tools for simple tasks to powerful systems capable of…

An AI powered system automating remote patient monitoring by analyzing real time health data and vital signs, futuristic AI-driven healthcare platform

Science Through an Artistic Lens

In a world where scientific innovation is increasingly interconnected, the RepliFate-Artist in Residence program seeks to…

Cellular Reprogramming Necklace by Anna Dumitriu photo credit Audrey Rose Mizzi large_QUER

Tracing the First Building Blocks of Life

What connects Helmholtz Munich with space research? The globally unique analytical methods developed by Prof. Philippe…

Bennu polycam mosaic obtained before spacecraft arrival

Prof. Sandra Hummel, lead scientist of the research area “Lifestyle, Obesity, and Epigenetic Programming in Type 1 and Gestational Diabetes” at the Institute of Diabetes Research at Helmholtz Munich, has been awarded the Dr. Heinz Bürger-Büsing…

Helmholtz Biomedical Engineering Initiative

The Helmholtz Association is launching a nationwide biomedical engineering initiative to accelerate technology development and transfer activities. Led by its established Health Centers, “Helmholtz Biomedical Engineering” brings together cutting-edge…

Helmholtz Munich coordinates a new €4.9 million Horizon Europe project that will support cities with science-based strategies to reduce pollution and protect public health.

corona virus 2019-ncov flu outbreak, covid-19 3d banner illustration, microscopic view of floating influenza virus cells

The German National Cohort (NAKO) contributes its scientific expertise to the National Decade of Post-Infectious Diseases initiated by the Federal Ministry of Research, Technology and Space (BMFTR). With two central projects, it makes an important…

Ancient viral remnants embedded in the human genome may be an overlooked driver of Alzheimer’s disease. Dr. Michelle Vincendeau at Helmholtz Munich is investigating how so-called endogenous retroviruses influence disease-relevant mechanisms in human…

Numerous genetic studies have identified many risk variants for type 2 diabetes (T2D) – but which genes and proteins are actually involved in the disease mechanisms? An international team led by Helmholtz Munich has now used globally collected…

Healthy gut bacteria concept with natural probiotics for immune support.

Bacteria in the human gut can directly deliver proteins into human cells, actively shaping immune responses. Led by researchers at Helmholtz Munich, with participation from Ludwig Maximilians University (LMU), Aix Marseille University, Inserm, and…

Intricate network of red capillaries, a detailed view of microscopic blood vessels conveying vitality

Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed “fast-RSOM”, a new imaging technology that can capture detailed images of the smallest blood vessels directly through the skin – without the need for…

Big data technology data science analysis

A new artificial intelligence (AI) method called BioPathNet helps researchers systematically search large biological data networks for hidden connections – from gene functions and disease mechanisms to potential therapeutic approaches. BioPathNet was…

Maria Keller mit einer Kollegin im Labor

Dr. habil. Maria Keller, team leader at the Helmholtz Institute for Metabolic, Obesity, and Vascular Research (HI-MAG), an institute of Helmholtz Munich at the University of Leipzig and University of Leipzig Medical Center, has successfully secured…

Cachexia is a metabolic disorder that causes uncontrolled weight loss and muscle wasting in chronic diseases and cancer. A new study by Helmholtz Munich, in collaboration with the Institute of Physiology of the Czech Academy of Sciences in Prague,…

A magnified view of the large intestine's surface, showing its muscular wall and fatty tissue

Abdominal fat is not a uniform tissue. A new study from Helmholtz Munich, Karolinska Institutet and Steno Diabetes Center Copenhagen, published in Cell Metabolism, reveals that fat located close to the large intestine contains an unusually high…

Detailed view of a computer interface used by geneticists showing a complex genome mapping software

With single-cell technologies, researchers can measure millions of cells in parallel and track how each one responds to specific perturbations – targeted interventions such as drug treatments, changes in gene activity or disease-like conditions.…

Researchers have conducted the most comprehensive analysis to date linking plasma proteins to genetic variation in individuals from continental Africa. Their work addresses a long-standing gap by studying a population grossly underrepresented in…

For the first time, an international analysis has shown that when people with prediabetes bring their blood glucose back into the normal range through lifestyle changes, their risk of heart attack, heart failure, and premature death is cut in half.…

The European Commission has appointed Prof. Eleftheria Zeggini, Director of the Institute of Translational Genomics at Helmholtz Munich, to the Scientific Council of the European Research Council (ERC). Alongside five newly selected members, she will…

Dr. Jian Cui, principal investigator at the Helmholtz Pioneer Campus, has been awarded an ERC Consolidator Grant for his project PhotonSignaling. As part of Helmholtz Munich’s innovation hub, Cui belongs to a generation of “Pioneers” turning bold…

Research into a novel form of cell death is entering its next phase and could soon help reduce complications after heart attacks or organ transplants. The Federal Ministry of Research, Technology, and Space (BMFTR) is providing continued support for…

Dr. Raffaele Teperino, Principal Investigator of the Environmental Epigenetics Group at Helmholtz Munich, has been honored with the PRO-SCIENTIA Award 2025 of the Eckhart-Buddecke Foundation. The award, endowed with 10,000 euros, recognizes…

Researchers at Helmholtz Munich, the Technical University of Munich and the LMU University Hospital Munich uncovered a mechanism that protects nerve cells from premature cell death, known as ferroptosis. The study provides the first molecular…

Core facilities support and enable our center’s research by providing centralized access to cutting-edge technologies, instruments and highly skilled staff, fostering innovation and connecting scientists across disciplines.

Find out more

Artificial Intelligence in Healthcare - New AI Applications in Medicine

Our cutting-edge research forms the basis for medical innovations. Together with our partners, we are accelerating the transfer of our research to bring new ideas from the laboratories to application even faster.
n addition to implementing innovative diagnostics, medical technologies, sustainable prevention measures and personalized therapeutics, we are shaping a dialogical and interactive transfer of knowledge. In this way, we make a valuable contribution to a healthier society.

More information

Eleftheria Zeggini

"We discover breakthrough solutions for better health in a rapidly changing world."

to Eleftheria's page

Prof. Dr. Eleftheria Zeggini

Program Director ENABLE

Stephan Herzig

"It is my vision to successfully drive a mechanistic finding into clinical application in the area of obesity-related metabolic dysfunction as well as cancer cachexia."

to Stephan's page

Prof. Dr. Stephan Herzig

Director of the Diabetes Center, Scientific Director

Martin Hrabě de Angelis

"Leading science means guiding discovery toward public good – with excellence, integrity, and impact."

to Martin's page

Prof. Dr. Dr. h.c. Martin Hrabě de Angelis

Member and Spokesperson of the Executive Board (acting), Director of the Institute of Experimental Genetics, Scientific Director

Fabian Theis

"With AI we can imagine a future where diagnosing and treating diseases is more affordable, widely available, and thus more democratic."

to Fabian's page

Prof. Dr. Fabian Theis

Director of the Computational Health Center

Vasilis Ntziachristos

"Our research at Helmholtz Munich is driven by our interest to provide solutions that address critical unmet medical need and positively impact healthcare and the well-being of society."

Prof. Dr. Vasilis Ntziachristos

Director of the Bioengineering Center

Erika von Mutius

"I am a passionate pediatrician scientist. My research focusses on the roots of asthma and allergy development with the aim of ultimately preventing these diseases in children at risk."

Prof. Dr. Erika von Mutius

Director of the Environmental Health Center

Magdalena Götz

"My vision is to explore the mechanisms of neurogenesis to use it for instructing neurogenesis for replacement of lost neurons."

Prof. Dr. Magdalena Götz

Director of the Stem Cell Center

Michael Sattler

"We combine integrative structural biology to elucidate molecular mechanisms of biological pathways, highlighting the essential roles of dynamics and transient regulatory interations to enable innovative structure-based drug discovery."

to Michael´s page

Prof. Dr. Michael Sattler

Director of the Molecular Targets & Therapeutics Center

We collaborate with a dynamic network of regional and international partners. Together, we engage in impactful projects and cooperations that shape the future of medicine.
Read more

Blue and white sphere network structure - abstract design connection design - 3D illustration

Our Research.

Our Research.

On This Page

How Foundation Models Are Shaping Biomedical Research

Science Through an Artistic Lens

Tracing the First Building Blocks of Life

Sandra Hummel Awarded the Dr. Heinz Bürger-Büsing Prize

Helmholtz Biomedical Engineering Initiative: Shaping the Future of Health

PUREPOLIS: New EU Project for Cleaner, Healthier Cities

NAKO Participates in the National Decade of Post-Infectious Diseases

Can Ancient Viral Remnants Trigger Alzheimer’s Disease?

Big Data Make Hidden Genetic Drivers of Type 2 Diabetes Visible

More Than Just Gut Cohabitants: How Gut Bacteria Control Immune Responses

New Imaging Technology Detects Early Signs of Heart Disease Through the Skin

BioPathNet: New AI Uncovers Hidden Patterns in Biomedical Knowledge Graphs

Adipose Tissue Under the Microscope: Funding for Two Metabolic Health Projects

Weight Loss in Cancer: Organs Respond to the Disease in a Coordinated Way

Not All Belly Fat Is the Same: Colon-Adjacent Fat Interacts With the Immune System

Pertpy: A Software Toolbox Reveals How Individual Cells Respond to Therapies

Mapping Proteins in African Genomes Reveals New Paths to Fight Type 2 Diabetes

Normalizing Blood Sugar Can Halve Heart Attack Risk

Eleftheria Zeggini Appointed to ERC Scientific Council

Jian Cui Wins Prestigious ERC Consolidator Grant

Funding for Cell Death Research Extended

PRO-SCIENTIA Award for Raffaele Teperino

Single Enzyme Failure Found to Drive Neuron Loss in Dementia

Eleftheria Zeggini

Stephan Herzig

Martin Hrabě de Angelis

Fabian Theis

Vasilis Ntziachristos

Erika von Mutius

Magdalena Götz

Michael Sattler